Video Experimental Relacionado
Updated: Aug 12, 2026

09:32
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
Published on: February 8, 2018
Múltiples antígenos específicos del tumor expresados en una sola célula tumoral
Nature
|July 14, 1983
Resumen
Los tumores tienen antígenos únicos que activan la defensa inmune. Los investigadores descubrieron que un fibrosarcoma inducido por rayos UV tiene múltiples antígenos específicos de tumores simultáneos, lo que revela una antigenización tumoral compleja.
Área de la Ciencia:
- Inmunología Inmunología.
- Oncología Oncología.
- Investigación del cáncer Investigación del cáncer.
Sus antecedentes:
- Los antígenos específicos del tumor (ATS) son cruciales para las respuestas inmunes antitumorales.
- La complejidad y diversidad de las AAT en tumores individuales sigue siendo en gran medida desconocida.
- La radiación ultravioleta (UV) es un conocido carcinógeno que induce antígenos tumorales específicos.
Objetivo del estudio:
- Para caracterizar la antigenicidad única de un fibrosarcoma murino inducido por la luz ultravioleta (UV).
- Para investigar la complejidad y la composición de antígenos específicos de tumores (TSA) en este modelo.
- Comprender el papel de los cambios antigénicos en la vigilancia y el escape inmunológico del tumor.
Principales métodos:
- Utilizó sondas de células T monoclonales definidas para analizar las variantes tumorales.
- Variantes tumorales seleccionadas in vitro utilizando sondas de células T.
- Caracterizó la antigenicidad del modelo de fibrosarcoma inducido por UV.
Principales resultados:
- El fibrosarcoma murino inducido por rayos UV exhibe antigenicidad compleja.
- La antigenicidad total comprende múltiples componentes independientes y específicos del tumor.
- Todos los componentes antigénicos identificados se expresan simultáneamente en la misma célula tumoral.
Conclusiones:
- Los fibrosarcomas inducidos por rayos UV poseen un complejo repertorio de antígenos específicos del tumor.
- Esta complejidad antigénica es una característica clave de la vigilancia y el escape inmunológico del tumor.
- Estudios adicionales ahora pueden identificar componentes moleculares y sus roles en la inmunidad antitumoral.
Videos de Conceptos Relacionados
Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

